For patients with RCC who respond to PD-1 blockade, do you ever discuss stopping treatment?  

If so, at what point? McDermott et al. demonstrated some lasting responses after discontinuation of therapy (JCO 2015), but these responses are still unpredictable.



Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution

Medical Oncologist

Answer from: Medical Oncologist at Academic Institution